Efficacy, safety, and pharmacokinetics of imatinib dose escalation to 800 mg/day in patients with advanced gastrointestinal stromal tumors

Overview of attention for article published in Investigational New Drugs, April 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

wikipedia: 3 Wikipedia pages

Citations

dimensions_citation: 23 Dimensions

Readers on

mendeley: 15 Mendeley

Summary Policy documents Wikipedia Dimensions citations

So far, Altmetric has seen 0 policy documents that reference this research output.

Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinib

Cited by Finnish Environment Institute (Syke) on 15 Nov 2017

At the Finnish Environment Institute (Syke), we offer strong expertise and independent information on global phenomena such as climate change, biodiversity loss, overconsumption, pollution and eutrophication.